Novanta Inc. (NOVT)
| Market Cap | 4.80B |
| Revenue (ttm) | 980.60M |
| Net Income (ttm) | 53.83M |
| Shares Out | 35.68M |
| EPS (ttm) | 1.47 |
| PE Ratio | 91.45 |
| Forward PE | 37.73 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 374,921 |
| Open | 134.40 |
| Previous Close | 136.64 |
| Day's Range | 130.88 - 134.58 |
| 52-Week Range | 98.27 - 150.18 |
| Beta | 1.62 |
| Analysts | Hold |
| Price Target | 133.00 (-1.06%) |
| Earnings Date | Feb 23, 2026 |
About NOVT
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s... [Read more]
Financial Performance
In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for NOVT stock is "Hold" and the 12-month stock price target is $133.0.
News
Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript
Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter 2025 resu...
Goldman Sachs Small/Mid Cap Growth Fund Q3 2025 Portfolio Update
The Goldman Sachs Small/Mid Cap Growth Fund-Institutional Shares underperformed its benchmark, the Russell 2500 Growth Index (net), during the quarter. We initiated a position in Planet Fitness, Inc. ...
Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Chuck Ravetto, Chief...
Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
5 Tech And Consumer Stocks At Risk Of Steep Declines
As the market grows increasingly top-heavy, the risks for fundamentally weaker and average-strength companies are increasing. The number of stocks losing momentum over the past year has mounted as meg...
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has ...
Novanta Inc. Announces Offering of Tangible Equity Units
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has ...
Novanta Inc. (NOVT) Q3 2025 Earnings Call Transcript
Novanta Inc. ( NOVT) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ray Nash - Corporate Finance Leader & IR Matthijs Glastra - CEO & Chairman of the Board Robert Buckley - C...
Novanta Announces Financial Results for the Third Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...
Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Hosts ISO event for Humanoid Robot Safety Standards
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced industrial OEMs, announced that it will host an International Organization for Standardizatio...
Novanta to Present at the Baird 2025 Global Industrial Conference on Tuesday, November 11, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2025 resul...
Novanta's Board of Directors Authorizes Additional $200 Million for Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directo...
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Matthijs Glastra - CEO & Chairman of the Board Ray Nash - Corporate Participant Corporate F...
Novanta Announces Financial Results for the Second Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 resu...
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Ch...
Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT) Q1 2025 Results Conference Call May 6, 2025 10:00 AM ET Company Participants Ray Nash - Investor Relations Matthijs Glastra - Chair & Chief Executive Officer Robert Buckley...
Novanta Announces Financial Results for the First Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial res...